Live Price
Live Volume
Biogen Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $220.83 |
|---|---|
| Close | $220.90 |
| Low | $220.83 |
| Low Change | 0.00 (0.00%) |
| High | $220.90 |
| High Change | +0.07 (+0.03%) |
| Range | $0.07 |
| Volume | 121.621K |
| Dollar Volume | $26.87M |
Regular Trading Hours
| Open | $220.73 |
|---|---|
| Close | $220.97 |
| Low | $219.82 |
| Low Change | -0.91 (-0.41%) |
| High | $223.82 |
| High Change | +3.09 (+1.40%) |
| Range | $4.00 |
| Volume | 327.844K |
| Dollar Volume | $72.44M |
Premarket
| Open | $221.00 |
|---|---|
| Close | $220.94 |
| Low | $220.94 |
| Low Change | -0.06 (-0.03%) |
| High | $221.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.06 |
| Volume | 581 |
| Dollar Volume | $128.37K |
After Hours Yesterday
| Open | $224.51 |
|---|---|
| Close | $224.51 |
| Low | $224.51 |
| Low Change | 0.00 (0.00%) |
| High | $224.51 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 182.622K |
| Dollar Volume | $41.00M |
Regular Trading Hours Yesterday
| Open | $225.44 |
|---|---|
| Close | $224.41 |
| Low | $221.23 |
| Low Change | -4.21 (-1.87%) |
| High | $225.80 |
| High Change | +0.36 (+0.16%) |
| Range | $4.57 |
| Volume | 334.478K |
| Dollar Volume | $75.06M |
Premarket Yesterday
| Open | $222.65 |
|---|---|
| Close | $224.98 |
| Low | $222.65 |
| Low Change | 0.00 (0.00%) |
| High | $225.00 |
| High Change | +2.35 (+1.06%) |
| Range | $2.35 |
| Volume | 701 |
| Dollar Volume | $157.71K |
Biogen News
3 weeks agoinvesting.comWolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- 1 month agoinvesting.com
Biogen beats quarterly estimates as newer drugs fuel growth
- 2 months agoinvesting.com
Biogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
- 2 months agoinvesting.com
Biogen stock rises on positive Alzheimer’s drug trial data
2 months agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
- 2 months agoinvesting.com
Why is Biogen stock rallying today?
- 2 months agoinvesting.com
Truist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key data
- 2 months agobarrons.com
Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details
- 2 months agobarrons.com
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
- 4 months agoinvesting.com
Biogen advances Alzheimer’s drug after mid-stage trial results
Biogen Top Trades
Biogen's top trade so far today returned +1.40%, while the top short trade returned -1.34%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $219.69 |
|---|---|
| 10 Day Moving Average (SMA10) | $219.66 |
| 20 Day Moving Average (SMA20) | $215.13 |
| 50 Day Moving Average (SMA50) | $209.17 |
| 100 Day Moving Average (SMA100) | $200.54 |
| 200 Day Moving Average (SMA200) | $190.77 |
Biogen Statistics
| Average Volume (30 Days) | 886.72K |
|---|---|
| P/E Ratio (Current) | 39.41 |
| EPS (Current) | $5.65 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.70B |
| Cash Ratio | 0.33 |
| Current Ratio | 1.87 |
| Quick Ratio | 1.26 |
| Debt to Equity | 0.43 |
| Enterprise Value | $39.71B |
| EV to EBITDA | 17.26 |
| EV to Sales | 3.96 |
| Price to Book | 1.75 |
| Price to Cash Flow | 11.43 |
| Price to Free Cash Flow | 12.20 |
| Price to Sales | 3.28 |
| Return on Assets | 0.03% |
| Return on Equity | 0.04% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).